Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.

Ophthalmology - 1 Oct 2013

Maguire Maureen G, Daniel Ebenezer, Shah Ankoor R, Grunwald Juan E, Hagstrom Stephanie A, Avery Robert L, Huang Jiayan, Martin Revell W, Roth Daniel B, Castellarin Alessandro A, Bakri Sophie J, Fine Stuart L, Martin Daniel F

Abstract excerpt

OBJECTIVE: To assess the influence of drug; dosing regimen; and traditional, nontraditional, and genetic risk factors on the incidence of choroidal neovascularization (CNV) in the fellow eye of patients treated for CNV with ranibizumab or bevacizumab. DESIGN: Cohort study of patients enrolled in a multicenter, randomized clinical trial. PARTICIPANTS: Patients with no CNV in the fellow eye at the time of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bevacizumab

Share to Choroidal Neovascularization

Share to Complement C3

Share to Complement Factor H

Share to High-Temperature Requirement A Serine Peptidase 1

Share to Intravitreal Injections

Source

Open in PubMed Open full text

Identifiers

PMID: 23706946
DOI: 10.1016/j.ophtha.2013.03.017
PMCID: PMC3758381

Genes

ARMS2
CFH
HTRA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.PMID 23706946Read ↗

Risk of scar in the comparison of age-related macular degeneration treatments trials.Semantic proximity Read ↗

Genetics in neovascular age-related macular degeneration susceptibility and treatment response to anti-VEGF intravitreal injection: A case series study.Semantic proximity Read ↗

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).Semantic proximity Read ↗

Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.Semantic proximity Read ↗

Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design.Semantic proximity Read ↗

The Moorfields AMD Database Report 2 - Fellow Eye Involvement with Neovascular Age-related Macular DegenerationSemantic proximity Read ↗

Incidence of retinal pigment epithelium tears after intravitreal injection of Bevacizumab for the treatment of exudative age-related macular degenerationSemantic proximity Read ↗

VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).Semantic proximity Read ↗

Long-term outcome of neovascular age-related macular degeneration: association between treatment outcome and major risk alleles.Semantic proximity Read ↗

Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration.Semantic proximity Read ↗

Post-hoc analysis of single nucleotide polymorphism profile for eyes with vascularized pigment epithelial detachment due to ARMD.Semantic proximity Read ↗

Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.